Perez-Lloret S - Search Results

1

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.

Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Tison F, Rascol O; of the COPARK Study Group. Perez-Lloret S, et al. Eur J Neurol. 2017 Dec;24(12):1532-1538. doi: 10.1111/ene.13466. Epub 2017 Oct 9. Eur J Neurol. 2017. PMID: 28940893

2

Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine.

Merello M, Perez-Lloret S, Antico J, Obeso JA. Merello M, et al. J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):172-4. doi: 10.1136/jnnp.2005.068940. J Neurol Neurosurg Psychiatry. 2006. PMID: 16421117 Free PMC article.

3

Addenbrooke's Cognitive Examination validation in Parkinson's disease.

Reyes MA, Perez-Lloret S, Roldan Gerschcovich E, Martin ME, Leiguarda R, Merello M. Reyes MA, et al. Eur J Neurol. 2009 Jan;16(1):142-7. doi: 10.1111/j.1468-1331.2008.02384.x. Epub 2008 Nov 25. Eur J Neurol. 2009. PMID: 19049504 Clinical Trial.

4

Rotigotine transdermal delivery for the treatment of Parkinson's disease.

Rascol O, Perez-Lloret S. Rascol O, et al. Expert Opin Pharmacother. 2009 Mar;10(4):677-91. doi: 10.1517/14656560902746041. Expert Opin Pharmacother. 2009. PMID: 19239399 Review.

5

Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients.

Perez-Lloret S, Rossi M, Nouzeilles MI, Trenkwalder C, Cardinali DP, Merello M. Perez-Lloret S, et al. J Neurol. 2009 Sep;256(9):1480-4. doi: 10.1007/s00415-009-5141-3. Epub 2009 Apr 29. J Neurol. 2009. PMID: 19404716 Free PMC article.

6

Decision-making in Parkinson's disease patients with and without pathological gambling.

Rossi M, Gerschcovich ER, de Achaval D, Perez-Lloret S, Cerquetti D, Cammarota A, Inés Nouzeilles M, Fahrer R, Merello M, Leiguarda R. Rossi M, et al. Eur J Neurol. 2010 Jan;17(1):97-102. doi: 10.1111/j.1468-1331.2009.02792.x. Epub 2009 Sep 23. Eur J Neurol. 2010. PMID: 19780806

7

Actigraphic evaluation of motor fluctuations in patients with Parkinson's disease.

Perez Lloret S, Rossi M, Cardinali DP, Merello M. Perez Lloret S, et al. Int J Neurosci. 2010 Feb;120(2):137-43. doi: 10.3109/00207450903139663. Int J Neurosci. 2010. PMID: 20199206

8

Adverse drug reactions to dopamine agonists: a comparative study in the French Pharmacovigilance Database.

Perez-Lloret S, Bondon-Guitton E, Rascol O, Montastruc JL; French Association of Regional Pharmacovigilance Centers. Perez-Lloret S, et al. Mov Disord. 2010 Sep 15;25(12):1876-80. doi: 10.1002/mds.23204. Mov Disord. 2010. PMID: 20669320

9

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.

Perez Lloret S, Rascol O. Perez Lloret S, et al. Expert Opin Pharmacother. 2010 Sep;11(13):2221-30. doi: 10.1517/14656566.2010.510515. Expert Opin Pharmacother. 2010. PMID: 20670197 Review.

10

Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.

Perez-Lloret S, Rascol O. Perez-Lloret S, et al. CNS Drugs. 2010 Nov;24(11):941-68. doi: 10.2165/11537810-000000000-00000. CNS Drugs. 2010. PMID: 20932066 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters